FIELD: medicine; pharmaceutics.
SUBSTANCE: group of inventions relates to a compound of formula (Il) and specific compounds specified in clause 26, a pharmaceutical composition based thereon for mediating GABA activity, a method of treating a CNS-related disorder associated with GABA activity, and a method of sedation and/or anaesthesia by mediating GABA activity. In general formula (Il) each of R1a, R1b, R2a, R2b, R4a, R4b, R6a, R6b, R7a, R7b, R11a, R11b, R12a and R12b is hydrogen; R3a is ethyl, n-propyl, iso-propyl, n-butyl, cyclopropyl or cyclopropylmethyl; R18 is methyl; R19 is hydrogen, methyl or ethyl; RY is methyl; each RD is hydrogen; q is 0, 1, 2, 3, 4 or 5; and R55a and R55b are taken with intermediate atoms to form , where p is equal to 1, and Ra is -CN.
EFFECT: neuroactive steroids and methods of using them are disclosed.
58 cl, 3 tbl, 508 ex
Title | Year | Author | Number |
---|---|---|---|
AVB6 INTEGRIN INHIBITORS | 2018 |
|
RU2769702C2 |
COMPOSITIONS AND METHODS OF THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2799448C2 |
COMPOSITIONS AND METHODS OF TREATMENT OF DISEASES OF CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2810331C2 |
COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | 2018 |
|
RU2798342C2 |
NEUROACTIVE STEROIDS SUBSTITUTED AT POSITION 10 WITH A CYCLIC GROUP FOR USE IN THE TREATMENT OF CNS DISORDERS | 2019 |
|
RU2796006C2 |
USE OF PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTION | 2015 |
|
RU2704867C2 |
BENZAMIDE COMPOUNDS | 2019 |
|
RU2801647C2 |
ANTIFIBROUS PYRIDINONES | 2015 |
|
RU2692485C2 |
SUBSTITUTED 1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONES | 2019 |
|
RU2812726C2 |
TRICYCLIC COMPOUNDS AS EGFR INHIBITORS | 2021 |
|
RU2815022C1 |
Authors
Dates
2024-11-14—Published
2019-12-05—Filed